China has approved NEO, a coin-sized brain chip developed by Tsinghua University and Neuracle Technology, for commercial use after successful clinical trials. The less-invasive implant aims to help patients with spinal cord injuries and paralysis, potentially outpacing Elon Musk's Neuralink in commercialization.
Elon Musk's $1.1 trillion net worth dwarfs historical figures and fictional characters, but the real story is SpaceX's potential to build the next economy. Its valuation suggests a future beyond launch services, encompassing orbital construction, asteroid mining, and space habitats, akin to Amazon Web Services for space.
Elon Musk expressed confidence that Neuralink's brain implant technology will eventually restore hearing and vision. He stated the Blindsight implant aims to send visual information directly to the brain's visual cortex, bypassing damaged eyes or optic nerves.
Elon Musk's Neuralink is developing a surgical robot to implant its brain-computer interface, aiming to treat brain-related conditions. This robot, designed for precision and consistency, uses an ultrafine needle to insert electrode threads, automating a complex procedure. Neuralink's goal is a generalized neural interface to help thousands more people.
Zilis, an executive at Musk’s brain implant startup Neuralink, served on OpenAI’s board from 2020 to 2023Shivon Zilis, a Neuralink executive and the mother of four of Elon Musk’s children, took the stand on Wednesday as one of the most highly anticipated witnesses in Musk’s case against OpenAI. The ChatGPT maker has argued that, while Zilis worked with OpenAI between 2016 and 2023, she was also involved in a secret relationship with Musk, acting as an informant for him.Musk’s case against OpenAI alleges that the company’s CEO, Sam Altman, and president, Greg Brockman, co-founders of the company with Musk, broke a founding agreement when they restructured it from a non-profit to a for-profit enterprise. The Tesla CEO accuses Altman and Brockman of unjustly enriching themselves and wants both removed from their positions at the startup, one of the most valuable in the world. He is also seeking the undoing of the for-profit restructuring and $134bn in damages to be redistributed to OpenAI’s non-profit arm. Continue reading...
Zilis, an executive at Musk’s brain implant startup Neuralink, served on OpenAI’s board from 2020 to 2023Shivon Zilis, a Neuralink executive and the mother of four of Elon Musk’s children, took the stand on Wednesday as one of the most highly anticipated witnesses in Musk’s case against OpenAI. The ChatGPT maker has argued that, while Zilis worked with OpenAI between 2016 and 2023, she was also involved in a secret relationship with Musk, acting as an informant for him.Musk’s case against OpenAI alleges that the company’s CEO, Sam Altman, and president, Greg Brockman, co-founders of the company with Musk, broke a founding agreement when they restructured it from a non-profit to a for-profit enterprise. The Tesla CEO accuses Altman and Brockman of unjustly enriching themselves and wants both removed from their positions at the startup, one of the most valuable in the world. He is also seeking the undoing of the for-profit restructuring and $134bn in damages to be redistributed to OpenAI’s non-profit arm. Continue reading...
Emails submitted as evidence in the Musk v. Altman trial reveal Elon Musk privately warned his Neuralink associates that Google DeepMind was "moving very fast" and that OpenAI was "not on a path to catch up." Testimony from OpenAI president Greg Brockman further shows Musk was fixated on DeepMind CEO Demis Hassabis from OpenAI's earliest days — even questioning whether founding it as a non-profit had been a strategic mistake.
Emails submitted as evidence in the Musk v. Altman trial reveal Elon Musk privately warned his Neuralink associates that Google DeepMind was "moving very fast" and that OpenAI was "not on a path to catch up." Testimony from OpenAI president Greg Brockman further shows Musk was fixated on DeepMind CEO Demis Hassabis from OpenAI's earliest days — even questioning whether founding it as a non-profit had been a strategic mistake.
Neuralink ha ottenuto l'approvazione dalla FDA per condurre il suo primo studio clinico sull'uomo con impianti cerebrali, un passo cruciale per la tecnologia che mira a interfacciarsi con i computer.
